UK Endocrine Pathology Society

All the London Endocrine Pathology Update speakers' talks are now available for pay per view video access on Vimeo OTT for people who did not attend the conference; please see londonepu.vhx.tv

Join us at 2025 London Endocrine Pathology Update on 10th-11th February wix.to/KwbOSig #rsvpnow #savethedate

We deeply mourn the passing of Dr. Christopher Fletcher. His groundbreaking work and dedication to advancing pathology have left an indelible mark on the field. Our thoughts are with his loved ones. His legacy will forever inspire. #InMemoriam #PathologyLegend

Thyroid tumor with enlarged nuclei showing chromatin clearance, pseudoinclusions and grooves. Classic BRAF-like nuclear atypia. Only problem - this is RET mutated medullary thyroid carcinoma. Take home message: Be careful with MTCs, they may mimic anything.

Surgical approaches to thyroid cancer & pathology Reporting thyroid cytology using the UK ‘Thy’ system & discussion of the Bethesda system Risk stratification in thyroid cancer Pitfalls in thyroid diagnosis & medicolegal issues

Updated WHO Classification of Endocrine & Neuroendocrine Tumours of thyroid, parathyroid, adrenal cortex & phaeochromocytoma/paraganglioma Updates to RCPath datasets for carcinoma of thyroid, parathyroid, adrenal cortex & paraganglioma MDT’s & national guidelines

Slightly delayed but now finally published is a multidisciplinary UK H+N Cancer Guideline with contributions in the thyroid chapter 25 by Drs Agrawal, Chengot, Moonim, Natu & Poller cambridge.org/core/journals/…

Dr Bin Xu from MSCC in New York giving the plenary talk in the rare thyroid tumour session at The World Congress on Thyroid Carcinoma today in London. thyroidworldcongress.com

Members of the UKEPS will be presenting tomorrow in the rare thyroid tumour symposium

Day 2 of the UKEPS/RCPath Endocrine Pathology Update. Prof Neil Tolley from London talking about parathyroid surgery

The 1st lecture in the RCPath UKEPS endocrine pathology update has just commenced today. Giovanni Tallini talking about WHO 5th Ed & Thyroid tumours.

NICE Thyroid Cancer Guidance recommendations for more use of needle core biopsy after Thy1 & Thy3a FNA & use of ROSE after Thy1 if non (c) are the most significant for pathology & cytology BUT NCB for Thy3a nodules in most cases is not likely to be helpful nice.org.uk/guidance/ng230

Look out for a NICE Guideline 'Thyroid cancer: Assessment and Management' on 19th Dec. An earlier draft version in June '22 had various recommendations for pathology, cytology & thyroid MDT's so publication of the final version of this guideline document is awaited with interest!

@AshishC97225686 Yes, Grace had a true enthusiasm and interest in developments in her areas of practice, here ND rate for US guided thyroid FNA was ~1%. We had many emails over the years since I first met her at the 1stTBS meeting in Bethesda.

I was truly inspired by her enthusiasm and love for cytology at an ASC meeting only a few years ago when she emailed me with articles to support the discussion we had over coffee. RIP 🥲🙏❤️

UKEPS/RCPath Endocrine Pathology Update in London on 2 & 3rd February 2023, some amazing national & international speakers including Ronald Ghossein, Giovanni Tallini, Bin Xu, Kate Newbold & Neil Tolley rcpath.org/event/3rd-unit…

A theme of the next UKEPS online meeting on 21st April will be WSI & AI in thyroid/endocrine pathology Speakers Andrey Bychkov, Japan David Snead, UK Shonali Natu, UK The sessions will be recorded We hope to make the transcripts available after via UKEPS.com

Our president, Sarah Johnson, speaking today at the ESP/BDIAP joint symposium on Endocrine Pathology/Cytopathology symposium on diagnosis of thyroid nodules.